Moderna’s dual COVID-flu vaccine moves to late-stage trial after signs of success

Moderna plans to begin a late-stage trial later this year of its combination vaccines that offer protection against both COVID-19 and the flu. Dr. Stephanie Navarro Silvera, a professor in the Department of Public Health at Montclair State University, explains why a dual shot would be considered “a win in terms of public health.” Source